glp-1 cognitive benefits Frontiers Surprising Benefits of GLP-1 Medications

Homocysteine, inflammation, and the brain When B12 is low, homocysteine accumulates

GIP (Glucose-dependent Insulinotropic Polypeptide): Another incretin hormone produced in the intestines Stimulates insulin secretion from the pancreas Enhances fat metabolism Affects how the body stores and uses energy May amplify the appetite-suppressing effects of GLP-1 The Combined Effect: When both GLP-1 and GIP pathways are activated together: Stronger insulin response: better blood sugar control Enhanced fat burning: greater weight loss More appetite suppression: reduced food intake Slower gastric emptying: prolonged fullness (and potential problems) Clinical Advantages of Tirzepatide Greater Weight Loss: Clinical trials showed tirzepatide produced: Average weight loss: 20-25% of body weight Compared to semaglutide: 15-20% Some patients lost 30%+ of their starting weight Faster Results: Many patients report: Quicker onset of appetite suppression More rapid weight loss in the first months Stronger fullness sensation after meals Superior Glucose Control: For diabetic patients: Greater A1C reductions than semaglutide More patients reaching target A1C goals Fewer patients needing additional diabetes medications Potential Disadvantages and Risks 1

The Market Correction in Obesity Care And Weight Management The GLP-1 market is undergoing a systemic reset evolving from a direct-to-consumer boom into a payer-driven infrastructure play

, , ,

Adv Nutr 10(suppl_1):S49S66 Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K et al (2020) The international scientific association for probiotics and prebiotics (isapp) consensus statement on the definition and scope of synbiotics

The NAAG storage cycle provides a mechanism for cancer cells to store this important metabolic product by converting glutamate produced from glutamine into NAAG and then back into glutamate, thus providing a mechanism for storing this important metabolic product under stress conditions such as inhibition of glutamine breakdown [37] (Fig